Glargine insulin
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
University of Minnesota
Overview
Glargine insulin is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Glargine insulin clinical trials
Explore related
Medical disclaimer. This page summarizes research about Glargine insulin for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.